CRISPR Therapeutics (CRSP)
(Delayed Data from NSDQ)
$55.24 USD
-0.49 (-0.88%)
Updated May 24, 2024 04:00 PM ET
After-Market: $55.75 +0.51 (0.92%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Brokerage Reports
0 items in cart
CRISPR Therapeutics AG [CRSP]
Reports for Purchase
Showing records 181 - 200 ( 209 total )
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
1Q20: Four Programs in the Clinic. IND Approved for the Fifth
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Healthcare - Key Takeaways From Our KOL Event Series at ASH 2019
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Healthcare - ASH 2019: Don''t Miss Our KOL Event Series at ASH!
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Don''t Need an Eraser to Edit. Key Takeaways from Our Call with Dr. Soni.
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Join The Call Today at 1 PM To Discuss Treatments for Hemoglobinopathies
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Healthcare - ASH 2019: Meet the Doctors Who Will Speak at Our KOL Event Series
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
ASH 2019: Keep Your Eyes Peeled For These Presentations!
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Gene-Editing Is Clearly Not A Fiction. Reiterate Buy. PT Raised To $100.
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
Company: CRISPR Therapeutics AG
Industry: Medical - Biomedical and Genetics
KOL Call with Dr. Sandeep Soni on December 4, 2019 at 1pm ET
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T